
Decoding Dyslexia: Genetic Testing in Specific Learning Disabilities
Explore how genetic testing aids dyslexia management through early detection, personalized education plans, and reducing stigma, offering new insights and interventions.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing aids dyslexia management through early detection, personalized education plans, and reducing stigma, offering new insights and interventions.

Explore Spinocerebellar Ataxia 7, a neurodegenerative disorder, and learn how genetic testing aids in early diagnosis, family planning, and guiding treatment.

Explore how genetic testing aids in diagnosing and managing Spinocerebellar Ataxia with Epilepsy, enhancing early detection, tailored treatments, and familial insights.

Explore the role of genetic testing in diagnosing thyroid gland carcinoma. Understand genetic mutations, familial risk, and links with carotid body tumors.

Explore the impact of genetic testing on diagnosing Vein of Galen aneurysmal malformation, enhancing accuracy, guiding treatments, and advancing research.

Explore Von Willebrand Disease Type 2A, its genetic basis, and how genetic testing personalizes treatment, predicts disease progression, and aids family planning.

Explore how genetic testing revolutionizes Von Willebrand Disease Type 2B diagnosis and management, offering precise treatments and aiding family planning decisions.

Genetic testing enhances diagnosis and management of von Willebrand disease type 2M by identifying specific mutations, guiding treatment, and aiding family planning.